Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.535 EUR | -7.25% | -5.25% | -2.54% |
05-20 | Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096 | CI |
03-06 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.54% | 36.32M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- HRTIS Stock
- News Herantis Pharma Oyj
- Transcript : Herantis Pharma Oyj, H2 2021 Earnings Call, Mar 03, 2022